"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada.
(Photo: AFP/Giuseppe Cacace)
Jul 30, 2015
In a decision hailed as "great news" and "long overdue," the regulator Health Canada announced Thursday that it has approved use of the medical abortion pill known as RU-486, sold under the brand name Mifegymiso.
"The decision to authorize Mifegymiso for the Canadian market was made further to a thorough review of the data package provided by the sponsor that supported the safety, efficacy and quality of the product," said the agency.
An application of approval for the pill, which is also known as mifepristone, has been before the regulatory agency since December 2012. While its use will now be permitted, it can only be obtained through a physician's prescription and is allowed up to seven weeks after fertilization.
Regulators made the decision on Monday and on Wednesday notified drug manufacturer Linepharma, which will soon begin producing the pill.
"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada, in a press statement, adding that the pill "has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It's long overdue that Canadian women also have access to the gold standard for medical abortion care."
According to NAF, the pill will become available in Canada in 2016.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Our Summer Campaign is now underway, and there’s never been a more urgent time for Common Dreams to be as vigilant as possible. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Sarah Lazare
Sarah Lazare was a staff writer for Common Dreams from 2013-2016. She is currently web editor and reporter for In These Times.
canadapublic healthreproductive rightswomenabortion pillsabortion rightsnational abortion federationmifepristone
In a decision hailed as "great news" and "long overdue," the regulator Health Canada announced Thursday that it has approved use of the medical abortion pill known as RU-486, sold under the brand name Mifegymiso.
"The decision to authorize Mifegymiso for the Canadian market was made further to a thorough review of the data package provided by the sponsor that supported the safety, efficacy and quality of the product," said the agency.
An application of approval for the pill, which is also known as mifepristone, has been before the regulatory agency since December 2012. While its use will now be permitted, it can only be obtained through a physician's prescription and is allowed up to seven weeks after fertilization.
Regulators made the decision on Monday and on Wednesday notified drug manufacturer Linepharma, which will soon begin producing the pill.
"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada, in a press statement, adding that the pill "has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It's long overdue that Canadian women also have access to the gold standard for medical abortion care."
According to NAF, the pill will become available in Canada in 2016.
Sarah Lazare
Sarah Lazare was a staff writer for Common Dreams from 2013-2016. She is currently web editor and reporter for In These Times.
In a decision hailed as "great news" and "long overdue," the regulator Health Canada announced Thursday that it has approved use of the medical abortion pill known as RU-486, sold under the brand name Mifegymiso.
"The decision to authorize Mifegymiso for the Canadian market was made further to a thorough review of the data package provided by the sponsor that supported the safety, efficacy and quality of the product," said the agency.
An application of approval for the pill, which is also known as mifepristone, has been before the regulatory agency since December 2012. While its use will now be permitted, it can only be obtained through a physician's prescription and is allowed up to seven weeks after fertilization.
Regulators made the decision on Monday and on Wednesday notified drug manufacturer Linepharma, which will soon begin producing the pill.
"The approval of mifepristone is great news for women in Canada," said Vicki Saporta, president and CEO of the National Abortion Federation (NAF) and NAF Canada, in a press statement, adding that the pill "has been safely and effectively used by millions of women worldwide to terminate an early pregnancy since 1988, and is available in 60 other countries. It's long overdue that Canadian women also have access to the gold standard for medical abortion care."
According to NAF, the pill will become available in Canada in 2016.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.